Rochester, NY 7/11/2009 12:15:57 AM
Afternoon Shakers - SNY - Sanofi-Aventis study shows Lantus safety on eyes
Sanofi-Aventis SNY
Afternoon Shakers - SNY - Sanofi-Aventis study shows Lantus safety on eyes
---
Sanofi-Aventis SNY
Last Trade: 28.85
Day's Range: 28.60 - 29.15
52wk Range: 23.95 - 37.11
Volume: 902,587
COMPANY "In The News"
Drug developer Sanofi-Aventis said Monday its long-acting insulin Lantus was as safe in a five-year study as older types of insulin, specifically in cases of poor eyesight and blindness.
COMPANY DETAILS
Sanofi-Aventis, a pharmaceutical company, contributes to enhancing life by providing an offering of medicines, vaccines, and integrated healthcare solutions adapted to local needs and means primarily in Europe and the United States. The company has products in the areas of thrombosis, cardiovascular, metabolic diseases, oncology, central nervous system, internal medicine, and vaccines.
---
At WhisperfromWallStreet.com we specialize in understand the markets, particularly the penny stock market and understand what makes penny stocks increase. In a word it is exposure and by that we mean making the investing public aware of a particular stock, via an investor awareness campaign. Our tracking is second to none with our alerts in 2009 producing an average price gain of 80%+. If you'd like to track our results or receive your own alerts based on our experience, sign up now at... WhisperfromWallStreet.com
---
It's important that every investor be aware of our disclaimer which can be read in its entirety :
http://whisperfromwallstreet.com/disclaimer.php
IMPORTANT NOTE: This is not a solicitation to buy or sell any securities. WhisperfromWallStreet.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
